Cystatin D (CST5): An ultra-early inflammatory biomarker of traumatic brain injury
Abstract Traumatic brain injury (TBI) is set to become the leading cause of neurological disability across all age groups. Currently, no reliable biomarkers exist to help diagnose the severity of TBI to identify patients who are at risk of developing secondary injuries. Thus, the discovery of reliab...
Guardado en:
Autores principales: | Lisa J. Hill, Valentina Di Pietro, Jon Hazeldine, David Davies, Emma Toman, Ann Logan, Antonio Belli |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2017
|
Materias: | |
Acceso en línea: | https://doaj.org/article/2e3ced1b215147288577674f59227d2d |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Fusion or Fission: The Destiny of Mitochondria In Traumatic Brain Injury of Different Severities
por: Valentina Di Pietro, et al.
Publicado: (2017) -
The role of salivary vesicles as a potential inflammatory biomarker to detect traumatic brain injury in mixed martial artists
por: Rani Matuk, et al.
Publicado: (2021) -
Biomarkers in traumatic brain injury (TBI): a review
por: Dadas A, et al.
Publicado: (2018) -
Traumatic Brain Injury and Neuroinflammation: Review of the Main Biomarkers
por: A. I. Zudova, et al.
Publicado: (2020) -
The development of individual cognitive stimulation therapy (iCST) for dementia
por: Yates LA, et al.
Publicado: (2014)